Johnson & Johnson will not be undertaking local trials for its single-shot COVID-19 vaccine in India.
That's according to a report in The Economic Times on Tuesday, citing a company spokesperson.
While J&J had sought approval for conducting bridging trials in the country, the US-based drugmaker said it wouldn't have to do that now since India has scrapped that requirement,
The company is exploring how to accelerate the availability of its vaccine in India, the newspaper added.


Saudi Arabia intercepts and destroys drone in Mecca region
Six feared dead in helicopter crash in Indian Himalayan state, media report
Residents leave Russian-occupied Oleshky under truce brokered by Melania Trump
Four killed as Italian helicopter in EU mission in Bosnia crashes
